Your browser doesn't support javascript.
loading
The effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on the OCT-measured macular choroidal thickness of eyes with proliferative diabetic retinopathy
Preti, Rony C; Mutti, Anibal; Ferraz, Daniel A; Zacharias, Leandro C; Nakashima, Yoshitaka; Takahashi, Walter Y; Monteiro, Mario LR.
  • Preti, Rony C; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Mutti, Anibal; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Ferraz, Daniel A; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Zacharias, Leandro C; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Nakashima, Yoshitaka; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Takahashi, Walter Y; Universidade de São Paulo. Oftalmologia. São Paulo. BR
  • Monteiro, Mario LR; Universidade de São Paulo. Oftalmologia. São Paulo. BR
Clinics ; 72(2): 81-86, Feb. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-840045
ABSTRACT

OBJECTIVES:

To investigate the effect of laser pan-retinal photocoagulation with or without intravitreal bevacizumab injections on macular choroidal thickness parameters in eyes with high-risk proliferative diabetic retinopathy.

METHODS:

High-risk proliferative diabetic retinopathy patients undergoing laser treatment were prospectively enrolled in this study. One eye was randomly selected for laser treatment combined with bevacizumab injections, study group, whereas the corresponding eye was subjected to laser treatment alone, control group. Spectral-domain optical coherence tomography with enhanced depth imaging was used to measure the macular choroidal thickness prior to and 1 month after treatment. Measurements in both groups were compared. Clinicaltrials.gov NCT01389505.

RESULTS:

Nineteen patients (38 eyes) with a mean±standard deviation age of 53.4±9.3 years were evaluated, and choroidal thickness measurements for 15 patients were used for comparison. The greatest measurement before treatment was the subfoveal choroidal thickness (341.68±67.66 μm and 345.79±83.66 μm for the study and control groups, respectively). No significant difference between groups was found in terms of macular choroidal thickness measurements at baseline or after treatment. However, within-group comparisons revealed a significant increase in choroidal thickness parameters in 10 measurements in the study group and in only 5 temporal measurements in the control group when 1-month follow-up measurements were compared to baseline values.

CONCLUSIONS:

The macular choroidal thickness does not appear to be significantly influenced by laser treatment alone but increases significantly when associated with bevacizumab injections in patients with proliferative diabetic retinopathy and macular edema. Because bevacizumab injections reduce short-term laser pan-retinal photocoagulation-induced macular edema, our findings suggest that the choroid participates in its pathogenesis.
Asunto(s)


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Retina / Coroides / Inhibidores de la Angiogénesis / Retinopatía Diabética / Bevacizumab Tipo de estudio: Estudio observacional / Factores de riesgo Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Clinics Asunto de la revista: Medicina Año: 2017 Tipo del documento: Artículo / Documento de proyecto País de afiliación: Brasil Institución/País de afiliación: Universidade de São Paulo/BR

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Retina / Coroides / Inhibidores de la Angiogénesis / Retinopatía Diabética / Bevacizumab Tipo de estudio: Estudio observacional / Factores de riesgo Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Clinics Asunto de la revista: Medicina Año: 2017 Tipo del documento: Artículo / Documento de proyecto País de afiliación: Brasil Institución/País de afiliación: Universidade de São Paulo/BR